Wei Dai

Sichuan Cancer Hospital

Papers

1

Total Citations

22

H-Index

1

About

Wei Dai is an emerging researcher in the field of thoracic surgery, with a particular focus on minimally invasive surgical techniques for the treatment of non-small cell lung cancer (NSCLC). His work centers on the comparative evaluation of cutting-edge surgical approaches, notably examining the differences between multiportal robotic-assisted thoracoscopic surgery (RATS) and uniportal video-assisted thoracoscopic surgery (VATS) — two of the most advanced techniques in modern thoracic oncology. Dai's most recognized contribution, published in 2024 and already accumulating 22 citations within a short timeframe, investigates early postoperative patient-reported outcomes, placing the patient experience at the forefront of surgical evaluation rather than relying solely on clinical metrics. This patient-centered methodology represents an important shift in how surgical efficacy is measured and understood. By generating comparative evidence that directly informs surgical decision-making for lung cancer patients, Dai's research holds meaningful implications for improving quality of life following thoracic procedures. His rapid citation impact suggests growing recognition within the surgical and oncological communities, marking him as a promising voice in the evolving landscape of minimally invasive thoracic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of early postoperative patient-reported outcomes after multiportal robotic-assisted thoracoscopic surgery and uniportal video-assisted thoracoscopic surgery for non-small cell lung cancer
22 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Sichuan Cancer Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago